Laurence M. Corash
Net Worth
Last updated:
What is Laurence M. Corash net worth?
The estimated net worth of Dr. Laurence M. Corash is at least $16,352,518 as of 14 Mar 2024. He owns shares worth $2,784,291 as insider, has earned $604,147 from insider trading and has received compensation worth at least $12,964,080 in Cerus Corporation.
What is the salary of Laurence M. Corash?
Dr. Laurence M. Corash salary is $682,320 per year as Co-Founder & Chief Scientific Officer in Cerus Corporation.
How old is Laurence M. Corash?
Dr. Laurence M. Corash is 81 years old, born in 1944.
What stocks does Laurence M. Corash currently own?
As insider, Dr. Laurence M. Corash owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Cerus Corporation (CERS) | Co-Founder & Chief Scientific Officer | 2,339,740 | $1.19 | $2,784,291 |
What does Cerus Corporation do?
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Laurence M. Corash insider trading
Cerus Corporation
Dr. Laurence M. Corash has made 12 insider trades between 2006-2024, according to the Form 4 filled with the SEC. Most recently he sold 14,360 units of CERS stock worth $28,347 on 14 Mar 2024.
The largest trade he's ever made was exercising 162,750 units of CERS stock on 3 Oct 2014. As of 14 Mar 2024 he still owns at least 2,339,740 units of CERS stock.
Cerus key executives
Cerus Corporation executives and other stock owners filed with the SEC:
- Dr. Laurence M. Corash (81) Co-Founder & Chief Scientific Officer
- Dr. Richard J. Benjamin (65) Chief Medical Officer
- Mr. Kevin D. Green (53) Vice President of Fin. & Chief Financial Officer
- Mr. Vivek K. Jayaraman (50) Chief Operating Officer
- Mr. William M. Greenman (58) Pres, Chief Executive Officer & Director